This advisory brief incorporates learnings from TGaS Advisors’ 2023 Spring Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges.
Leaders from more than 100 emerging, mid tier and large tier biopharmaceutical companies attended function specific sessions. Leaders shared perspectives, made recommendations and collectively thought through alternative paths for key decisions for today and beyond.
Complete the form below to access the full advisory brief
What You Need to Know Now to Be Prepared for 2024
Highlights from TGaS Advisors’ Fall Summit How are Biopharmaceutical organizations evolving to develop capabilities and propel innovation for 2024 and beyond? Executive leaders in Commercial Operations, Medical Affairs and Market Access are focused on making informed decisions to propel the evolution of their organizations in this rapidly changing global economy. As you strategize to accelerate […]
2023 Annual Digital Marketing Competency Report
Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a […]
Simplifying the Complex: Data and Operational Challenges in Incentive Compensation
Available On Demand
Siloed approaches and communication problems are common hurdles that leaders focused on Incentive Compensation (IC) in life sciences face. Complex and proliferating data streams are another. Join Susheel Sukhtankar, Partner & Head of Commercial Analytics, as he hosts panelists Cheryl Crawford, SVP of Data Management & Commercial Operations, Jim Castello, VP of Field Operations & […]